Scholarlink

<p>The gut–brain axis (GBA) represents a complex, bidirectional communication network between the gut microbiome and the central nervous system, influencing both neurological health and the pathogenesis of various diseases. This review explores the integrative role of neuroimaging and machine learning (ML) in advancing our understanding of microbiota–brain interactions, emphasizing their combined potential to uncover novel biomarkers and therapeutic targets. Neuroimaging techniques, including functional magnetic resonance imaging (MRI), diffusion tensor imaging, and structural MRI, have revealed how gut microbiota imbalances, or dysbiosis, affect key brain networks and structural connectivity, contributing to cognitive dysfunction, emotional disturbances, and neurodegenerative conditions. ML methodologies, including deep learning (DL) and multimodal data fusion, are proving indispensable in extracting meaningful insights from high-dimensional neuroimaging and microbiome datasets. Supervised approaches, such as random forests and deep neural networks, have achieved high accuracy in predicting neurological outcomes based on microbial signatures, while unsupervised learning identifies distinct microbiota–brain connectivity patterns associated with disorders such as autism spectrum disorder and depression. Additionally, explainable AI (XAI) techniques are being increasingly applied to enhance the interpretability of ML-driven biomarker discovery, shedding light on the neuroprotective effects of butyrate-producing bacteria (e.g., <i>Faecalibacterium</i>, <i>Roseburia</i>) and the potential for neuroinflammation linked to an overabundance of <i>Proteobacteria</i>. These findings point to the transformative potential of combining neuroimaging and ML in precision medicine, offering a new paradigm for the diagnosis and treatment of neurological disorders ranging from irritable bowel syndrome to Alzheimer’s disease. However, challenges related to data harmonization, generalizability across populations, and establishing causal relationships remain, necessitating further research to realize the full clinical potential of this approach.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Decoding the gut–brain axis: toward AI-driven integration of neuroimaging and gut microbiota in human health

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月9日

查看全文
  • Dezhi Wu,
  • Hui Wang,
  • Yueqiong Ni,
  • Yurun Lu,
  • Yong Wang,
  • Huating Li,
  • Luonan Chen

摘要

The gut–brain axis (GBA) represents a complex, bidirectional communication network between the gut microbiome and the central nervous system, influencing both neurological health and the pathogenesis of various diseases. This review explores the integrative role of neuroimaging and machine learning (ML) in advancing our understanding of microbiota–brain interactions, emphasizing their combined potential to uncover novel biomarkers and therapeutic targets. Neuroimaging techniques, including functional magnetic resonance imaging (MRI), diffusion tensor imaging, and structural MRI, have revealed how gut microbiota imbalances, or dysbiosis, affect key brain networks and structural connectivity, contributing to cognitive dysfunction, emotional disturbances, and neurodegenerative conditions. ML methodologies, including deep learning (DL) and multimodal data fusion, are proving indispensable in extracting meaningful insights from high-dimensional neuroimaging and microbiome datasets. Supervised approaches, such as random forests and deep neural networks, have achieved high accuracy in predicting neurological outcomes based on microbial signatures, while unsupervised learning identifies distinct microbiota–brain connectivity patterns associated with disorders such as autism spectrum disorder and depression. Additionally, explainable AI (XAI) techniques are being increasingly applied to enhance the interpretability of ML-driven biomarker discovery, shedding light on the neuroprotective effects of butyrate-producing bacteria (e.g., Faecalibacterium, Roseburia) and the potential for neuroinflammation linked to an overabundance of Proteobacteria. These findings point to the transformative potential of combining neuroimaging and ML in precision medicine, offering a new paradigm for the diagnosis and treatment of neurological disorders ranging from irritable bowel syndrome to Alzheimer’s disease. However, challenges related to data harmonization, generalizability across populations, and establishing causal relationships remain, necessitating further research to realize the full clinical potential of this approach.